AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24661040 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie diet (≤ 1000 kcal per day) for 8 weeks
Number of subjects: 262
Study 24661040 — intervention group
Group type: COMPARATOR
Intervention: Normal diet (control group)
Number of subjects: 262
Study 23717119 — intervention group
Group type: EXPERIMENTAL
Intervention: Red ginseng (4,500 mg daily for 2 weeks)
Number of subjects: 15
Study 23717119 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 20401747 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo) 40,000 IU
Number of subjects: 19
Study 20401747 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 19
Study 17918277 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc‐interleukin‐2 scintigraphy
Number of subjects: 42
Study 17918277 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide therapy (25 mg/kg/day)
Number of subjects: 42
Study 17259791 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 150 mg/day
Number of subjects: 46
Study 17259791 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg/day
Number of subjects: 46
Study 14698695 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiepileptic drugs (AEDs)
Number of subjects: 37
Study 14698695 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative AED treatment
Number of subjects: 37
Study 14698695 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events incidence and participant withdrawal rates
Number of subjects: 37
Study 11270479 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin plus 5-methoxytryptamine (1 mg/day orally in the early afternoon)
Number of subjects: 30
Study 11270479 — intervention group
Group type: COMPARATOR
Intervention: Melatonin alone (20 mg/day orally in the evening)
Number of subjects: 30
Study 9252932 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafarelin (200 micrograms twice daily)
Number of subjects: 192
Study 9252932 — intervention group
Group type: COMPARATOR
Intervention: Leuprolide acetate depot (3.75 mg once monthly)
Number of subjects: 192
Study 8495861 — intervention group
Group type: EXPERIMENTAL
Intervention: Thromboprophylaxis during the perioperative period
Number of subjects: 0
Study 8495861 — intervention group
Group type: COMPARATOR
Intervention: Long-term thromboprophylaxis
Number of subjects: 0
Study 3307549 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (P)
Number of subjects: 30
Study 3307549 — intervention group
Group type: COMPARATOR
Intervention: Methohexital (M)
Number of subjects: 30
Study 31154805 — intervention group
Group type: EXPERIMENTAL
Intervention: Late winter (n = 98)
Number of subjects: 150
Study 31154805 — intervention group
Group type: EXPERIMENTAL
Intervention: Late summer (n = 52)
Number of subjects: 150
Study 31154805 — intervention group
Group type: EXPERIMENTAL
Intervention: Children aged 24–48 months
Number of subjects: 150
Study 31154805 — intervention group
Group type: EXPERIMENTAL
Intervention: Children not using formula milk
Number of subjects: 150
Study 31154805 — intervention group
Group type: EXPERIMENTAL
Intervention: Children not adhering to supplementation guidelines
Number of subjects: 150
Study 27561449 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine containing induction
Number of subjects: 125
Study 27561449 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 125
Study 27561449 — intervention group
Group type: COMPARATOR
Intervention: CK+ MK− and CK+ MK+
Number of subjects: 125
Study 24282477 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 mg caffeine
Number of subjects: 21
Study 24282477 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 lx blue light
Number of subjects: 21
Study 24282477 — intervention group
Group type: COMPARATOR
Intervention: white light/placebo
Number of subjects: 21
Study 24282477 — intervention group
Group type: COMPARATOR
Intervention: blue light/placebo
Number of subjects: 21
Study 21315212 — intervention group
Group type: COMPARATOR
Intervention: Heparin plus GP IIb/IIIa inhibitor
Number of subjects: 10836
Study 21315212 — intervention group
Group type: COMPARATOR
Intervention: Bivalirudin plus GP IIb/IIIa inhibitor
Number of subjects: 10836
Study 21315212 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin monotherapy
Number of subjects: 10836
Study 19394350 — intervention group
Group type: EXPERIMENTAL
Intervention: High viscosity (HV) yogurt
Number of subjects: 46
Study 19394350 — intervention group
Group type: EXPERIMENTAL
Intervention: Low viscosity (LV) yogurt
Number of subjects: 46
Study 17489290 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention associated with a particular stimulus class (pictures or words)
Number of subjects: 0
Study 17489290 — intervention group
Group type: EXPERIMENTAL
Intervention: Material-specific interference effect across two experiments
Number of subjects: 0
Study 17489290 — intervention group
Group type: EXPERIMENTAL
Intervention: Blocking manipulation in another experiment
Number of subjects: 0
Study 12618736 — intervention group
Group type: EXPERIMENTAL
Intervention: DC shock (90 patients)
Number of subjects: 180
Study 12618736 — intervention group
Group type: COMPARATOR
Intervention: Drugs (90 patients)
Number of subjects: 180
Study 10883557 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT), 7-week group intervention
Number of subjects: 60
Study 10883557 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring/waiting-list control
Number of subjects: 60
Study 10883557 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 60
Study 8840935 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive subjects (financial incentive to sleep)
Number of subjects: 14
Study 8840935 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (no incentive)
Number of subjects: 14
Study 1621749 — intervention group
Group type: EXPERIMENTAL
Intervention: Loracarbef (400 mg twice daily)
Number of subjects: 0
Study 1621749 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate (500/125 mg three times a day)
Number of subjects: 0
Study 1621749 — intervention group
Group type: EXPERIMENTAL
Intervention: Loracarbef
Number of subjects: 0
Study 1621749 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 0
Study 6431211 — intervention group
Group type: EXPERIMENTAL
Intervention: Milacemide 400 mg
Number of subjects: 12
Study 6431211 — intervention group
Group type: EXPERIMENTAL
Intervention: Milacemide 800 mg
Number of subjects: 12
Study 6431211 — intervention group
Group type: EXPERIMENTAL
Intervention: Milacemide 1600 mg
Number of subjects: 12
Study 6431211 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate 600 mg
Number of subjects: 12
Study 6431211 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 6431211 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam 1600 mg
Number of subjects: 12
Study 31119782 — intervention group
Group type: EXPERIMENTAL
Intervention: Yanhuning injection combined with azithromycin
Number of subjects: 16144
Study 31119782 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduning injection combined with azithromycin
Number of subjects: 16144
Study 31119782 — intervention group
Group type: COMPARATOR
Intervention: Azithromycin only
Number of subjects: 16144
Study 30788925 — intervention group
Group type: EXPERIMENTAL
Intervention: Monocycle (Group A: dexamethasone 40 mg once a day, from day 1 to day 4)
Number of subjects: 93
Study 30788925 — intervention group
Group type: EXPERIMENTAL
Intervention: Dicycle (Group B: dexamethasone 40 mg once a day, from day 1 to day 4, day 15 to day 18)
Number of subjects: 93
Study 30788925 — intervention group
Group type: EXPERIMENTAL
Intervention: Tri-cycle (Group C: dexamethasone 40 mg once a day, from day 1 to day 4, day 15 to day 18, day 29 to day 32)
Number of subjects: 93
Study 30788925 — intervention group
Group type: EXPERIMENTAL
Intervention: Monocycle (Group A)
Number of subjects: 93
Study 30788925 — intervention group
Group type: EXPERIMENTAL
Intervention: Dicycle (Group B)
Number of subjects: 93
Study 30788925 — intervention group
Group type: EXPERIMENTAL
Intervention: Tri-cycle (Group C)
Number of subjects: 93
Study 26920104 — intervention group
Group type: EXPERIMENTAL
Intervention: 750mg levornidazole every 24h (q24h)
Number of subjects: 24
Study 26920104 — intervention group
Group type: COMPARATOR
Intervention: 500mg levornidazole every 12h (q12h)
Number of subjects: 24
Study 25171270 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily protein intake (DPI) above the median (mean DPI of >1 g/kg)
Number of subjects: 159
Study 25171270 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily protein intake (DPI) below the median (mean DPI of 0.5 g/kg/day)
Number of subjects: 159
Study 25171270 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower DPI
Number of subjects: 159
Study 25171270 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox proportional hazards models and time-adjusted analysis
Number of subjects: 159
Study 23207335 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir monotherapy for 2 years
Number of subjects: 52
Study 23207335 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir monotherapy for 3 years
Number of subjects: 52
Study 23207335 — intervention group
Group type: COMPARATOR
Intervention: Control (non‐antiviral treatment)
Number of subjects: 52
Study 20708900 — intervention group
Group type: EXPERIMENTAL
Intervention: MI-consistent behaviors (MICO)
Number of subjects: 149
Study 20708900 — intervention group
Group type: EXPERIMENTAL
Intervention: MI-inconsistent behaviors (MIIN)
Number of subjects: 149
Study 20708900 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflective listening (a type of MICO behavior)
Number of subjects: 149
Study 17955941 — intervention group
Group type: EXPERIMENTAL
Intervention: CX717 200 mg
Number of subjects: 48
Study 17955941 — intervention group
Group type: EXPERIMENTAL
Intervention: CX717 400 mg
Number of subjects: 48
Study 17955941 — intervention group
Group type: EXPERIMENTAL
Intervention: CX717 1000 mg
Number of subjects: 48
Study 17955941 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 17955941 — intervention group
Group type: EXPERIMENTAL
Intervention: CX717
Number of subjects: 48
Study 15878536 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 268
Study 15878536 — intervention group
Group type: COMPARATOR
Intervention: Best medical treatment
Number of subjects: 268
Study 15878536 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 268
Study 15878536 — intervention group
Group type: COMPARATOR
Intervention: Unsuitable for stenting
Number of subjects: 268
Study 11991779 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased morning warm-up (200% of standard volume: 2,011.68 m)
Number of subjects: 10
Study 11991779 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced afternoon warm-up (33% of standard warm-up volume)
Number of subjects: 10
Study 11991779 — intervention group
Group type: COMPARATOR
Intervention: Standard morning warm-up (2,011.68 m)
Number of subjects: 10
Study 11991779 — intervention group
Group type: COMPARATOR
Intervention: Reduced afternoon warm-up (100% of standard warm-up volume)
Number of subjects: 10
Study 9708959 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolcapone 100 mg 3 times daily
Number of subjects: 215
Study 9708959 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolcapone 200 mg 3 times daily
Number of subjects: 215
Study 9708959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 215
Study 9708959 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolcapone (both doses)
Number of subjects: 215
Study 9150038 — intervention group
Group type: COMPARATOR
Intervention: First generation periodontal probe
Number of subjects: 6
Study 9150038 — intervention group
Group type: COMPARATOR
Intervention: Third generation periodontal probe
Number of subjects: 6
Study 9150038 — intervention group
Group type: COMPARATOR
Intervention: Inter-probe measurements
Number of subjects: 6
Study 9150038 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-probe measurements
Number of subjects: 6
Study 2328754 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.4 mg/kg rectally as premedication
Number of subjects: 20
Study 2328754 — intervention group
Group type: COMPARATOR
Intervention: Control group (no midazolam)
Number of subjects: 20
Study 6804244 — intervention group
Group type: EXPERIMENTAL
Intervention: desmethyldiazepam (20 mg/kg/day) for one week
Number of subjects: 6
Study 31519550 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low-phosphate diet (phosphate-to-protein ratio of 8 mg/g)
Number of subjects: 35
Study 31519550 — intervention group
Group type: COMPARATOR
Intervention: Low-phosphate diet (phosphate-to-protein ratio of 10 mg/g)
Number of subjects: 35
Study 31519550 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low-phosphate diet
Number of subjects: 35
Study 31519550 — intervention group
Group type: COMPARATOR
Intervention: Low-phosphate diet
Number of subjects: 35
Study 29280664 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplement with stevia and L-carnitine
Number of subjects: 19
Study 29280664 — intervention group
Group type: COMPARATOR
Intervention: Glucose solution (SG)
Number of subjects: 19
Study 29280664 — intervention group
Group type: COMPARATOR
Intervention: White bread (PB)
Number of subjects: 19
Study 25719814 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted instruction (educational computer programs)
Number of subjects: 263
Study 25719814 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer use experience
Number of subjects: 263
Study 25719814 — intervention group
Group type: EXPERIMENTAL
Intervention: Health insurance
Number of subjects: 263
Study 24679851 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) applied to the irradiated side of the face after surgery
Number of subjects: 10
Study 24679851 — intervention group
Group type: COMPARATOR
Intervention: Non-irradiated side (simulated control)
Number of subjects: 10
Study 22466911 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolic acid (MPA)
Number of subjects: 21
Study 20062928 — intervention group
Group type: EXPERIMENTAL
Intervention: DZ-697b 60 mg
Number of subjects: 20
Study 20062928 — intervention group
Group type: EXPERIMENTAL
Intervention: DZ-697b 120 mg
Number of subjects: 20
Study 20062928 — intervention group
Group type: EXPERIMENTAL
Intervention: DZ-697b 360 mg
Number of subjects: 20
Study 20062928 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 300 mg
Number of subjects: 20
Study 18048822 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy
Number of subjects: 804
Study 18048822 — intervention group
Group type: COMPARATOR
Intervention: Conventional-dose chemotherapy
Number of subjects: 804
Study 18048822 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (high-dose and conventional-dose chemotherapy)
Number of subjects: 804
Study 18048822 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with lower educational level and many complaints before chemotherapy
Number of subjects: 804
Study 16214509 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercostal muscle flap
Number of subjects: 114
Study 16214509 — intervention group
Group type: COMPARATOR
Intervention: Standard posterior-lateral thoracotomy
Number of subjects: 114
Study 15493239 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly explicit, teacher-directed instructional routine teaching three planning strategies (goal setting, brainstorming, organizing)
Number of subjects: 0
Study 15493239 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly explicit, teacher-directed instructional routine
Number of subjects: 0
Study 15493239 — intervention group
Group type: COMPARATOR
Intervention: Process writing instruction (Control)
Number of subjects: 0
Study 15493239 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly explicit, teacher-directed strategy instructional routine
Number of subjects: 0
Study 10102174 — intervention group
Group type: EXPERIMENTAL
Intervention: Preconception counseling addressing nutrition, prevention and prediction of preeclampsia, prenatal visits, fetal surveillance, risk of superimposed preeclampsia, recurrence risks, diagnosis of underlying factors, and impact on maternal and fetal health.
Number of subjects: 0
Study 10102174 — intervention group
Group type: EXPERIMENTAL
Intervention: Reviewing existing literature with patients in a nondirective manner and providing prenatal care.
Number of subjects: 0
Study 7755941 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg verapamil (V) twice a day
Number of subjects: 24
Study 7755941 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg terazosin (T) titrated weekly to 5 mg daily
Number of subjects: 24
Study 7755941 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (T added to V or V added to T)
Number of subjects: 24
Study 7755941 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy (group TV)
Number of subjects: 24
Study 7755941 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy (group VT)
Number of subjects: 24
Study 7755941 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (T and V)
Number of subjects: 24
Study 2233205 — intervention group
Group type: EXPERIMENTAL
Intervention: TM-Rel (Treadmill at relative VO2)
Number of subjects: 8
Study 37190 — intervention group
Group type: EXPERIMENTAL
Intervention: acebutolol hydrochloride (SECTRAL)
Number of subjects: 18
Study 37190 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 18
Study 29903889 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST) kits provided to patients, encouraged to report results to I Want the Kit (IWTK), and received referral cards for peers.
Number of subjects: 100
Study 29903889 — intervention group
Group type: COMPARATOR
Intervention: Control group received pamphlets about publicly available HIV testing sites.
Number of subjects: 100
Study 29903889 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST) kits provided to patients.
Number of subjects: 100
Study 29084336 — intervention group
Group type: EXPERIMENTAL
Intervention: s-lactam monotherapy
Number of subjects: 1418
Study 29084336 — intervention group
Group type: COMPARATOR
Intervention: s-lactam plus macrolide combination therapy
Number of subjects: 1418
Study 26114161 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental therapy (bevacizumab)
Number of subjects: 571
Study 26114161 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 571
Study 23897998 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation protocol B
Number of subjects: 40
Study 23897998 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation protocol A
Number of subjects: 40
Study 21723554 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tablets containing 3.4 mg of VPP and IPP
Number of subjects: 70
Study 21723554 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 70
Study 18986246 — intervention group
Group type: COMPARATOR
Intervention: C-ART
Number of subjects: 435
Study 18986246 — intervention group
Group type: EXPERIMENTAL
Intervention: 2/4-ART
Number of subjects: 435
Study 16752625 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular overdentures retained by 2 endosseous implants
Number of subjects: 151
Study 16752625 — intervention group
Group type: COMPARATOR
Intervention: Conventional dentures
Number of subjects: 151
Study 14998097 — intervention group
Group type: EXPERIMENTAL
Intervention: Equipment group (SAQ with specialized equipment)
Number of subjects: 36
Study 14998097 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-equipment group (SAQ with traditional equipment)
Number of subjects: 36
Study 14998097 — intervention group
Group type: COMPARATOR
Intervention: Active control group (regular fitness sessions)
Number of subjects: 36
Study 14998097 — intervention group
Group type: EXPERIMENTAL
Intervention: Equipment group
Number of subjects: 36
Study 14998097 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-equipment group
Number of subjects: 36
Study 14998097 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 36
Study 11544566 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynotest TRAK human assay
Number of subjects: 21
Study 11544566 — intervention group
Group type: COMPARATOR
Intervention: Porcine TBII assay
Number of subjects: 21
Study 9763796 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 9763796 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% Lactate
Number of subjects: 7
Study 9763796 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% CHO
Number of subjects: 7
Study 9763796 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% CHO + 2% Lactate
Number of subjects: 7
Study 10406437 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive brochure designed using the Motivation Generating model (Calcium CalculatorS)
Number of subjects: 216
Study 10406437 — intervention group
Group type: COMPARATOR
Intervention: Calcium information brochure (An Appetite for Good Health)
Number of subjects: 216
Study 2239124 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg bambuterol
Number of subjects: 39
Study 2239124 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg bambuterol
Number of subjects: 39
Study 2239124 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 329077 — intervention group
Group type: EXPERIMENTAL
Intervention: Tripotassium dicitrato-bismuthate (TDB)
Number of subjects: 56
Study 329077 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 30025414 — intervention group
Group type: EXPERIMENTAL
Intervention: 1L PEG NER1006 (N2D regimen)
Number of subjects: 849
Study 30025414 — intervention group
Group type: EXPERIMENTAL
Intervention: 1L PEG NER1006 (N1D regimen)
Number of subjects: 849
Study 30025414 — intervention group
Group type: COMPARATOR
Intervention: 2L polyethylene glycol + ascorbate (2LPEG)
Number of subjects: 849
Study 28760818 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard haematological care associated with palliative care (intervention group)
Number of subjects: 0
Study 28760818 — intervention group
Group type: COMPARATOR
Intervention: Standard haematological care with palliative care only if requested by the haematologist (control group)
Number of subjects: 0
Study 26530543 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity counseling (telephone contacts 3 times a week with real-time feedback)
Number of subjects: 30
Study 26530543 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 30